These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33588476)

  • 1. [Association between management factors and herd status regarding Porcine Reproductive and Respiratory Syndrome virus infection - An analysis in the course of a voluntary PRRSV control program in Saxony and Thuringia].
    David K; Vergara H; Eger S; Klassen A; Schwödiauer P; Reiner G; Donat K
    Tierarztl Prax Ausg G Grosstiere Nutztiere; 2021 Feb; 49(1):30-39. PubMed ID: 33588476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Porcine reproductive and respiratory syndrome control in Saxony and Thuringia - Results of 2 voluntary regional programmes in the years 2011-2018].
    Rettenberger K; Vergara H; Eger S; Schwödiauer P; Reiner G; Donat K
    Tierarztl Prax Ausg G Grosstiere Nutztiere; 2020 Apr; 48(2):80-91. PubMed ID: 32325496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody response and maternal immunity upon boosting PRRSV-immune sows with experimental farm-specific and commercial PRRSV vaccines.
    Geldhof MF; Van Breedam W; De Jong E; Lopez Rodriguez A; Karniychuk UU; Vanhee M; Van Doorsselaere J; Maes D; Nauwynck HJ
    Vet Microbiol; 2013 Dec; 167(3-4):260-71. PubMed ID: 24041768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of immunologic solutions on sows and gilts on time to stability, and production losses in breeding herds infected with 1-7-4 PRRSv.
    Linhares DCL; Betlach C; Morrison RB
    Prev Vet Med; 2017 Sep; 144():112-116. PubMed ID: 28716191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The PRRSV-serumneutralization test detects gaps in herd immunity].
    Böttcher J; Alex M; Janowetz B; Müller S; Schuh C; Niemeyer H
    Berl Munch Tierarztl Wochenschr; 2014; 127(7-8):305-13. PubMed ID: 25080824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control and eradication of porcine reproductive and respiratory syndrome virus type 2 using a modified-live type 2 vaccine in combination with a load, close, homogenise model: an area elimination study.
    Rathkjen PH; Dall J
    Acta Vet Scand; 2017 Jan; 59(1):4. PubMed ID: 28057035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elimination of porcine reproductive and respiratory syndrome virus infection using an inactivated vaccine in combination with a roll-over method in a Hungarian large-scale pig herd.
    Pertich A; Barna Z; Makai O; Farkas J; Molnár T; Bálint Á; Szabó I; Albert M
    Acta Vet Scand; 2022 May; 64(1):12. PubMed ID: 35525978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of a novel inactivated PRRS virus vaccine on virus replication and virus-induced pathology in fetal implantation sites and fetuses upon challenge.
    Karniychuk UU; Saha D; Vanhee M; Geldhof M; Cornillie P; Caij AB; De Regge N; Nauwynck HJ
    Theriogenology; 2012 Oct; 78(7):1527-37. PubMed ID: 22980086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A modified-live porcine reproductive and respiratory syndrome virus (PRRSV)-1 vaccine protects late-term pregnancy gilts against heterologous PRRSV-1 but not PRRSV-2 challenge.
    Jeong J; Kang I; Kim S; Park SJ; Park KH; Oh T; Yang S; Chae C
    Transbound Emerg Dis; 2018 Oct; 65(5):1227-1234. PubMed ID: 29536637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating perspectives for PRRS virus elimination from pig dense areas with a risk factor based herd index.
    Fahrion AS; Beilage Eg; Nathues H; Dürr S; Doherr MG
    Prev Vet Med; 2014 Jun; 114(3-4):247-58. PubMed ID: 24674019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of commercial modified-live PRRSV-1 and PRRSV-2 vaccines against a dual heterologous PRRSV-1 and PRRSV-2 challenge in late term pregnancy gilts.
    Yang S; Oh T; Cho H; Chae C
    Comp Immunol Microbiol Infect Dis; 2020 Apr; 69():101423. PubMed ID: 31972500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of four commercial PRRSV MLV vaccines in herds with co-circulation of PRRSV-1 and PRRSV-2.
    Oh T; Kim H; Park KH; Jeong J; Yang S; Kang I; Chae C
    Comp Immunol Microbiol Infect Dis; 2019 Apr; 63():66-73. PubMed ID: 30961820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A stochastic mathematical model of the within-herd transmission dynamics of Porcine Reproductive and Respiratory Syndrome Virus (PRRSV): fade-out and persistence.
    Evans CM; Medley GF; Creasey SJ; Green LE
    Prev Vet Med; 2010 Mar; 93(4):248-57. PubMed ID: 20004990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-protection of a modified-live porcine reproductive and respiratory syndrome virus (PRRSV)-2 vaccine against a heterologous PRRSV-1 challenge in late-term pregnancy gilts.
    Jeong J; Park C; Oh T; Park KH; Yang S; Kang I; Park SJ; Chae C
    Vet Microbiol; 2018 Sep; 223():119-125. PubMed ID: 30173737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamics and evolution of porcine reproductive and respiratory syndrome virus (PRRSV) ORF5 following modified live PRRSV vaccination in a PRRSV-infected herd.
    Nilubol D; Tripipat T; Hoonsuwan T; Tipsombatboon P; Piriyapongsa J
    Arch Virol; 2014 Jan; 159(1):17-27. PubMed ID: 23851653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of time to PRRSv-stability and production losses between two exposure programs to control PRRSv in sow herds.
    Linhares DC; Cano JP; Torremorell M; Morrison RB
    Prev Vet Med; 2014 Sep; 116(1-2):111-9. PubMed ID: 24931129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of infection with porcine circovirus-2 (PCV-2) and porcine reproductive and respiratory syndrome virus (PRRSV) in an integrated swine production system experiencing postweaning multisystemic wasting syndrome.
    Fraile L; Calsamiglia M; Mateu E; Espinal A; Cuxart A; Seminati C; Martín M; Domingo M; Segalés J
    Can J Vet Res; 2009 Oct; 73(4):308-12. PubMed ID: 20046634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous Infection With Porcine Reproductive and Respiratory Syndrome and Influenza Viruses Abrogates Clinical Protection Induced by Live Attenuated Porcine Reproductive and Respiratory Syndrome Vaccination.
    Chrun T; Maze EA; Vatzia E; Martini V; Paudyal B; Edmans MD; McNee A; Manjegowda T; Salguero FJ; Wanasen N; Koonpaew S; Graham SP; Tchilian E
    Front Immunol; 2021; 12():758368. PubMed ID: 34858411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term administration of a commercial porcine reproductive and respiratory syndrome virus (PRRSV)-inactivated vaccine in PRRSV-endemically infected sows.
    Papatsiros VG; Alexopoulos C; Kritas SK; Koptopoulos G; Nauwynck HJ; Pensaert MB; Kyriakis SC
    J Vet Med B Infect Dis Vet Public Health; 2006 Aug; 53(6):266-72. PubMed ID: 16907957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic and biological characterization of a Porcine Reproductive and Respiratory Syndrome Virus 2 (PRRSV-2) causing significant clinical disease in the field.
    Kvisgaard LK; Larsen LE; Hjulsager CK; Bøtner A; Rathkjen PH; Heegaard PMH; Bisgaard NP; Nielsen J; Hansen MS
    Vet Microbiol; 2017 Nov; 211():74-83. PubMed ID: 29102125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.